TG Therapeutics, Inc. (TGTX)
54.17
+1.01
(+1.90%)
USD |
NASDAQ |
Oct 23, 16:00
54.35
+0.18
(+0.33%)
After-Hours: 20:00
TG Therapeutics Market Cap : 8.292B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 8.292B |
| October 22, 2026 | 8.138B |
| October 21, 2026 | 8.144B |
| October 20, 2026 | 8.347B |
| October 19, 2026 | 8.159B |
| October 16, 2026 | 8.262B |
| October 15, 2026 | 8.572B |
| October 14, 2026 | 8.323B |
| October 13, 2026 | 8.318B |
| October 12, 2026 | 8.461B |
| October 09, 2026 | 8.476B |
| October 08, 2026 | 8.165B |
| October 07, 2026 | 8.105B |
| October 06, 2026 | 7.989B |
| October 05, 2026 | 8.252B |
| October 02, 2026 | 8.311B |
| October 01, 2026 | 8.208B |
| September 30, 2026 | 8.539B |
| September 29, 2026 | 8.601B |
| September 28, 2026 | 8.601B |
| September 25, 2026 | 8.791B |
| September 24, 2026 | 8.805B |
| September 23, 2026 | 8.572B |
| September 22, 2026 | 8.895B |
| September 21, 2026 | 8.750B |
| Date | Value |
|---|---|
| September 18, 2026 | 8.706B |
| September 17, 2026 | 8.644B |
| September 16, 2026 | 8.549B |
| September 15, 2026 | 8.119B |
| September 14, 2026 | 8.266B |
| September 11, 2026 | 8.249B |
| September 10, 2026 | 8.479B |
| September 09, 2026 | 8.366B |
| September 08, 2026 | 8.533B |
| September 04, 2026 | 8.570B |
| September 03, 2026 | 8.681B |
| September 02, 2026 | 8.710B |
| September 01, 2026 | 8.586B |
| August 31, 2026 | 8.312B |
| August 28, 2026 | 8.255B |
| August 27, 2026 | 8.529B |
| August 26, 2026 | 8.424B |
| August 25, 2026 | 8.484B |
| August 24, 2026 | 8.574B |
| August 21, 2026 | 8.308B |
| August 20, 2026 | 7.740B |
| August 19, 2026 | 7.913B |
| August 18, 2026 | 7.694B |
| August 17, 2026 | 7.544B |
| August 14, 2026 | 7.461B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Krystal Biotech, Inc. | 9.219B |
| Vertex Pharmaceuticals, Inc. | 132.74B |
| SELLAS Life Sciences Group, Inc. | 2.330B |
| Travere Therapeutics, Inc. | 4.716B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
Market Cap Related Metrics
| PE Ratio | 19.73 |
| PS Ratio | 10.80 |
| PEG Ratio | 0.0311 |
| Price to Book Value | 13.73 |
| Price to Free Cash Flow | 496.76 |
| Price | 54.17 |
| Earnings Yield | 5.07% |
| PEGY Ratio | 0.0311 |
| Operating PE Ratio | 63.35 |
| Normalized PE Ratio | 19.36 |